Skip to main content
. 2017 Jul 6;10(4):455–460. doi: 10.1093/ckj/sfx038

Fig. 1.

Fig. 1

Algorithm for minimizing the risk of hepatitis B virus reactivation in patients receiving ritumaxib. PCR, polymerase chain reaction.